Study on VPS72: Potential Drug Target Or Biomarker (G6944)

Target Name: VPS72

NCBI ID: G6944

VPS72

Study on VPS72: Potential Drug Target Or Biomarker

VPS72 (Tcfl1) is a protein that is expressed in many different tissues and cells in the body. It is a member of the T-cell leukemia family and is involved in the development and progression of various types of cancer. In recent years, researchers have been interested in studying VPS72 as a potential drug target or biomarker because of its unique structure and its involvement in the disease.

The VPS72 protein is composed of 254 amino acid residues and has a calculated molecular mass of 31.1 kDa. It is expressed in a variety of tissues, including the brain, spinal cord, heart, kidneys, and gastrointestinal tract. It is also expressed in cancer cells and has been identified as a potential drug target in several types of cancer, including leukemia, lung cancer, and colon cancer.

One of the key features of VPS72 is its role in the development and progression of cancer. Studies have shown that VPS72 is involved in the regulation of cell growth, differentiation, and survival, and that it plays a role in the development of cancer. For example, researchers have found that VPS72 is involved in the regulation of the DNA replication process, which is a critical step in cancer development. They have also shown that VPS72 is involved in the regulation of cell apoptosis, which is the process by which cells die naturally.

In addition to its role in cancer development, VPS72 has also been shown to be involved in the regulation of immune responses. Studies have shown that VPS72 is involved in the regulation of T-cell development and activation, and that it plays a role in the immune response. For example, researchers have found that VPS72 is involved in the regulation of the activation and proliferation of T-cells, and that it is involved in the regulation of their differentiation into memory T-cells.

Despite its involvement in so many different processes in the body, VPS72 is still a relatively well-studied protein. Only a few studies have been conducted on its role in cancer, and more research is needed to fully understand its potential as a drug target or biomarker.

One of the challenges in studying VPS72 is its complex structure. The protein is composed of a long, linear molecule that is involved in many different cellular processes. It is composed of multiple domains, including an N-terminus that is involved in protein-protein interactions and a C-terminus that is involved in cell surface interactions.

In addition to its complex structure, VPS72 is also known for its ability to interact with other proteins. Studies have shown that VPS72 is able to interact with a variety of proteins, including factors that are involved in cell growth, differentiation, and survival. For For example, VPS72 has been shown to interact with the protein tyrosine kinase (TK) to regulate its activity.

Another challenge in studying VPS72 is its role in multiple different diseases. While VPS72 has been shown to be involved in the development and progression of cancer, more research is needed to understand its potential role in other diseases. For example, studies have shown that VPS72 is involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In conclusion, VPS72 is a protein that is expressed in many different tissues and cells in the body and is involved in the development and progression of various types of cancer. Its unique structure and its involvement in the regulation of cell growth, differentiation, and survival make it an attractive target for drug development. Further research is needed to fully understand its potential as a drug

Protein Name: Vacuolar Protein Sorting 72 Homolog

Functions: Deposition-and-exchange histone chaperone specific for H2AZ1, specifically chaperones H2AZ1 and deposits it into nucleosomes. As component of the SRCAP complex, mediates the ATP-dependent exchange of histone H2AZ1/H2B dimers for nucleosomal H2A/H2B, leading to transcriptional regulation of selected genes by chromatin remodeling

The "VPS72 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VPS72 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets